# A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use

> **NCT05589857** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** IPAD
- **DEVICE:** Augmented Reality

## Key facts

- **NCT ID:** NCT05589857
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-25
- **Primary completion:** 2024-05-09
- **Final completion:** 2024-05-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No Patients Enrolles
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589857, "A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05589857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*